These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24466361)

  • 1. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal.
    Hasker E; Malaviya P; Gidwani K; Picado A; Ostyn B; Kansal S; Singh RP; Singh OP; Chourasia A; Kumar Singh A; Shankar R; Wilson ME; Khanal B; Rijal S; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2014; 8(1):e2657. PubMed ID: 24466361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study.
    Chakravarty J; Hasker E; Kansal S; Singh OP; Malaviya P; Singh AK; Chourasia A; Singh T; Sudarshan M; Singh AP; Singh B; Singh RP; Ostyn B; Fakiola M; Picado A; Menten J; Blackwell JM; Wilson ME; Sacks D; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007216. PubMed ID: 30917114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study.
    Ostyn B; Gidwani K; Khanal B; Picado A; Chappuis F; Singh SP; Rijal S; Sundar S; Boelaert M
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1284. PubMed ID: 21991397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent infection with Leishmania donovani in highly endemic villages in Bihar, India.
    Hasker E; Kansal S; Malaviya P; Gidwani K; Picado A; Singh RP; Chourasia A; Singh AK; Shankar R; Menten J; Wilson ME; Boelaert M; Sundar S
    PLoS Negl Trop Dis; 2013; 7(2):e2053. PubMed ID: 23459501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal.
    Picado A; Ostyn B; Singh SP; Uranw S; Hasker E; Rijal S; Sundar S; Boelaert M; Chappuis F
    PLoS One; 2014; 9(1):e87641. PubMed ID: 24498159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA.
    Khanal B; Rijal S; Ostyn B; Picado A; Gidwani K; Menten J; Jacquet D; Lejon V; Chappuis F; Boelaert M
    Trop Med Int Health; 2010 Nov; 15(11):1390-4. PubMed ID: 21998875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India.
    Gidwani K; Picado A; Ostyn B; Singh SP; Kumar R; Khanal B; Lejon V; Chappuis F; Boelaert M; Sundar S
    Clin Vaccine Immunol; 2011 Feb; 18(2):346-8. PubMed ID: 21159922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of asymptomatic infection to symptomatic visceral leishmaniasis: A study of possible immunological markers.
    Das VNR; Bimal S; Siddiqui NA; Kumar A; Pandey K; Sinha SK; Topno RK; Mahentesh V; Singh AK; Lal CS; Singh SK; Das P
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008272. PubMed ID: 32555598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis.
    Bhattacharyya T; Bowes DE; El-Safi S; Sundar S; Falconar AK; Singh OP; Kumar R; Ahmed O; Boelaert M; Miles MA
    PLoS Negl Trop Dis; 2014 Feb; 8(2):e2675. PubMed ID: 24587456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.
    Bern C; Jha SN; Joshi AB; Thakur GD; Bista MB
    Am J Trop Med Hyg; 2000; 63(3-4):153-7. PubMed ID: 11388508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seropositivity of Visceral leishmaniasis on people of VL endemic three districts of Nepal.
    Basnyat S; Banjara MR; Ghimire P; Matlashewski G; Singh A
    Parasitol Int; 2021 Feb; 80():102236. PubMed ID: 33147500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratorial algorithm for serological diagnosis of visceral leishmaniasis using rK39-ICT, DAT-LPC and FC-Simplex IgG1.
    do Vale INPC; Saliba JW; Fonseca GSF; Peruhype-Magalhães V; de Araújo FF; Pascoal-Xavier MA; Teixeira-Carvalho A; Campos FMF; Andrade MC; Lula JF; Reis AB; Lemos EM; de Carvalho SFG; Oliveira E; Martins-Filho OA
    J Immunol Methods; 2020 May; 480():112765. PubMed ID: 32119888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.
    Abass E; Kang C; Martinkovic F; Semião-Santos SJ; Sundar S; Walden P; Piarroux R; El Harith A; Lohoff M; Steinhoff U
    PLoS One; 2015; 10(3):e0116408. PubMed ID: 25734336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of asymptomatic Leishmania infection in Bangladesh by antibody and antigen diagnostic tools shows an association with post-kala-azar dermal leishmaniasis (PKDL) patients.
    Owen SI; Hossain F; Ghosh P; Chowdhury R; Hossain MS; Jewell C; Cruz I; Picado A; Mondal D; Adams ER
    Parasit Vectors; 2021 Feb; 14(1):111. PubMed ID: 33597000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.
    Ostyn B; Uranw S; Bhattarai NR; Das ML; Rai K; Tersago K; Pokhrel Y; Durnez L; Marasini B; Van der Auwera G; Dujardin JC; Coosemans M; Argaw D; Boelaert M; Rijal S
    PLoS Negl Trop Dis; 2015; 9(8):e0003966. PubMed ID: 26252494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological and Molecular Analysis of
    Kaushal H; Bhattacharya SK; Verma S; Salotra P
    Am J Trop Med Hyg; 2017 Jun; 96(6):1448-1455. PubMed ID: 28719266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Leishmania donovani in peripheral blood of asymptomatic individuals in contact with patients with visceral leishmaniasis.
    Banu SS; Meyer W; Ahmed BN; Kim R; Lee R
    Trans R Soc Trop Med Hyg; 2016 May; 110(5):286-93. PubMed ID: 27198212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of rK39 immunochromatographic test and direct agglutination test for the diagnosis of Mediterranean visceral leishmaniasis in Spain.
    Bangert M; Flores-Chávez MD; Llanes-Acevedo IP; Arcones C; Chicharro C; García E; Ortega S; Nieto J; Cruz I
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006277. PubMed ID: 29494596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal.
    Khanal B; Picado A; Bhattarai NR; Van Der Auwera G; Das ML; Ostyn B; Davies CR; Boelaert M; Dujardin JC; Rijal S
    Parasitology; 2010 Sep; 137(11):1597-603. PubMed ID: 20459877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the visceral leishmaniasis elimination initiative on Leishmania donovani transmission in Nepal: a 10-year repeat survey.
    Cloots K; Uranw S; Ostyn B; Bhattarai NR; Le Rutte E; Khanal B; Picado A; Chappuis F; Hasker E; Karki P; Rijal S; Boelaert M
    Lancet Glob Health; 2020 Feb; 8(2):e237-e243. PubMed ID: 31981555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.